Lipolysis in fat cells can be stimulated by catecholamines through subtypes of b-adrenergic receptors (b-ARs), and inhibited through a2-ARs. Associations of Trp64Arg substitution in the b3-AR gene with various anthropometric markers of obesity have been reported in several ethnic groups [1±3], although the role of the variant allele in traits related to obesity still remains controversial [4, 5] . Human adipose cells express not only b3-ARs but considerable amounts of b2-ARs. Several polymorphisms have been found in the coding region of the b2-AR gene in humans [6] . Among them, amino acid substitutions at position 16, 27, and 164 alter receptor functions [7, 8] . An association between the polymorphism at codon 27 of the b2-AR gene and obesity in white women has been reported [9] . To assess the role of the genetic variants of the b2-AR gene in susceptibility to obesity and obesity-related metabolic disorders, we analysed the polymorphisms in obese and non-obese subjects. Diabetologia (1999) Summary To assess the role of polymorphisms in the b2-adrenergic receptor gene in the development of obesity and obesity-related metabolic disorders, we analysed Arg16Gly, Gln27Glu, and Thr164Ile polymorphisms in 400 non-obese subjects (body mass index < 27 kg/m 2 ) and 108 obese subjects (body mass index ³ 27 kg/m 2 ). The Gln27Glu substitution was twice as common in obese subjects as in non-obese subjects (0.14 vs 0.07, p = 0.001, odds ratio 2.14, 95 % confidence interval 1.35±3.41). The frequency of the Glu27 allele was also higher in patients with Type II (non-insulin-dependent) diabetes mellitus than nondiabetic subjects (0.14 vs 0.07, p = 0.001, odds ratio 2.13, 95 % confidence interval 1.34±3.41). Analysis of variance of multiple variables showed an association between 2-h post-load glucose concentrations and body mass index but not with the Glu27 variant, suggesting that the association with diabetes could be secondary to obesity. Obese subjects carrying the variant allele had higher concentrations of serum triglyceride than obese subjects homozygous for the wild type allele (2.68 1.90 vs 1.18 1.15 mmol/l, p = 0.02). Conversely, the frequency of Gly16 homozygotes was lower in obese women when compared with non-obese women (11 % vs 28 %, p = 0.01, odds ratio 0.30, 95 % confidence interval 0.12±0.75), although the association was not present in male subjects. Thr164Ile substitution was not detected in the subjects of this study. These observations suggest that the amino-terminal polymorphisms of the b2-adrenergic receptor gene could be involved in the molecular pathogenesis of obesity and hypertriglyceridaemia, and thereby the development of Type II diabetes mellitus. [Diabetologia (1999) 42: 98±101] 
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Subjects and methods
Subjects. Subjects of this study consisted of two groups; 400 non-obese subjects with body mass index (BMI) less than 27 kg/m 2 randomly selected from patients who attended the Kumamoto Red Cross Health Care Centre for health screening, and 108 obese subjects (BMI > 27 kg/m 2 ) treated at the Kurume University Hospital. All subjects gave informed consent. The non-obese group (aged 50. Analysis of the polymorphisms. Genomic DNA was extracted from peripheral leucocytes by digestion with proteinase K followed by phenol/chloroform extraction. The amplification of b2-AR gene sequences was done by polymerase chain reaction (PCR) in a volume of 10 ml containing 0.1 U of AmpliTaq gold DNA polymerase (Takara, Otsu, Japan), 1.5 mmol/l of MgCl 2 , 100mmol/l of dNTPs, 10 mmol/l of Tris-HCl pH 8.3, 50 mmol/l of KCl, with following oligonucleotide primers: 5 ¢-CTT-CTTGCTGGCACGCAAT±3 ¢ and 5 ¢-CCAGTGAAGTGA-TGAAGTAGTTGG-3 ¢ for codon 16, 5 ¢-GGCCCATGAC-CAGATCAGCA-3 ¢ and 5 ¢-GAATGAGGCTTCCAGGCG-TC-3 ¢ for codon 27, 5 ¢-GGACTTTTGGCAACTTCTGG-3 ¢ and 5 ¢-ACGAAGACCATGATCACCAG-3 ¢ for codon 164. Dimethylsulphoxide was added at the concentration of 10 % when codon 27 sequence or codon 164 sequence was amplified. Anealing temperatures for codon 16, codon 27, and codon 164 were 56 C, 60 C, and 55 C, respectively. After 35 cycles of amplification, aliquots (2 ml) of PCR products were analysed on 2 % agarose gels to confirm the proper amplification. Then the amplified PCR products were digested with the addition of BsrD1 (codon 16), Ita1 (codon 27), or Mnl1 (codon 164). After an incubation for 2 h, the digested samples were separated by electrophoresis through 3 % agarose gel and made visible by staining with ethidium bromide.
Statistical analysis.
Values are given as means and SD. Differences between group means were estimated by the Student's unpaired t test. The chi-squared test was used to compare frequencies. A p value less than 0.05 was considered statistically significant. Relative risk was estimated by the odds ratios (ORs) and their 95 % confidence intervals (CIs). The significance of individual values was ascertained by the analysis of variance (ANOVA) using GLM procedure of SAS (SAS Institute, Carey, N. C., USA).
Results
Codon 16 of the b2-AR gene was highly polymorphic in the Japanese subjects ( Table 1 ). The incidence of Arg16Gly substitution was not significantly different between obese and non-obese subjects as a whole. In women, however, the Gly16 allele frequency tended to be lower in obese subjects when compared with non-obese subjects (0.39 vs 0.50, p = 0.06, OR 1.56, CI 0.98±2.48). Significant difference was obtained in the frequency of Gly16 homozygotes between obese women (11 %) and non-obese women (28 %, p = 0.01, OR 0.30, CI 0.12±0.75). The Glu27 allele frequency in obese subjects was twice as high as that in non-obese subjects (0.14 vs 0.07, p = 0.001, OR 2.14, CI 1.35±3.41). This association was significant both in male and female subjects (p = 0.04 and p = 0.03, respectively). Although BMI may be affected by diabetes and its treatment, there was no statistically significant difference in the duration of diabetes or the ratio of insulin treatment among Gln27 homozygotes, Gln27/Glu27 heterozygotes, and Glu27 homozygotes in the obese group. None of non-obese subjects was receiving insulin treatment. The Glu27 allele was detected only in 2 of 131 subjects homozygous for Arg16 allele, whereas 32 of 121 subjects homozygous for Gly16 allele carried the variant allele (Table 2) indicating that the Glu27 allele was in linkage disequilibrium to the Gly16 allele. All of the Glu27 homozygotes were homozygous for the Gly16 allele. Whereas, the homozygous Gly16/Gln27 genotype was obtained in 75 of 400 non-obese and 14 of 108 obese subjects. The wild type Gln27/Arg16 homozygous genotype was detected in 99 and 30 of non-obese and obese subjects, respectively. Thr164Ile substitution of the b2-AR gene was not observed in the subjects of this study.
Next we analysed the association of the polymorphisms in the b2-AR gene with glucose and lipid metabolism. The codon 16 polymorphism was not associated with glucose tolerance in either male or female subjects (Table 3) . However, the codon 27 variant allele was more common in diabetic subjects than in non-diabetic subjects (0.14 vs 0.07, p = 0.001, OR 2.13, CI 1.34±3.41). The BMIs of diabetic and non-diabetic subjects were 29.0 4.3, 23.5 3.3, respectively (p < 0.0001). Analysis of the association between the Glu27 allele and diabetes within each group, showed there tended to be an association in the nonobese subjects (0.14 vs 0.07, p = 0.08) but not in the obese subjects (0.14 vs 0.13, NS). To assess whether the Glu27 allele was directly associated with diabetes in the lean group, correlations of the genotype and BMI with plasma glucose concentrations were estimated by ANOVA. We found 2-h post-load plasma glucose concentration was associated with BMI (p = 0.002) but not with the Glu27 allele. Basal plasma glucose concentrations were not associated with either BMI or Glu27 variants.
In the obese group, subjects having the Glu27 allele showed higher concentrations of fasting serum triglyceride (2.68 1.90 mmol/l) than subjects without the variant (1.18 1.15 mmol/l, p = 0.02), although there was no difference in age between the subjects with and those without the variant allele (49.5 16.3 vs 47.9 16.3 years old), BMI (31.3 3.4 vs 31.1 3.6), serum cholesterol (5.35 ± 0.99 vs 5.38 1.02 mmol/l), glycohaemoglobin (7.1 2.0 vs 7.1 2.1 %), systolic blood pressure (132.4 19.1 vs 131.9 19.9 mmHg), or diastolic blood pressure (77.1 11.7 vs 76.5 11.0 mmHg). Since hypertriglyceridaemia could have resulted from diabetes, correlations of the Glu27 allele and glycohaemoglobin concentrations with serum triglyceride values were analysed as independent variables with ANOVA. Both the genotype and glycohaemoglobin concentrations were associated with those of serum triglyceride in the obese subjects (p = 0.004 and p = 0.026, respectively). On the other hand, no significant association was seen in the non-obese group between the codon 27 polymorphism and BMI, serum lipids, glycohaemoglobin concentrations, or blood pressure. Whereas, the codon 16 polymorphism was not associated with any of the above variables either in obese or non-obese subjects.
Discussion
In Swedish women obesity was found to be associated with the codon 27 polymorphism, but not with the codon 16 polymorphism [9] . In this study, the prevalence of Gly16 homozygotes was lower in obese women than in non-obese women (p = 0.01, OR 0.30, CI 0.12±0.75). This discrepancy could be explained by differing environmental influence or genetic background. Our observation accorded, however, with adipocytes from subjects homozygous for the Gly16 allele having fivefold higher sensitivity to b2-selective agonist terbutaline than those from subjects homozygous for the Arg16 allele [9] . Thus the Gly16 allele could be a resistant gene of obesity in female subjects.
In the Swedish study [9] obesity was associated only with homozygosity for Glu27. Although Glu27 homozygotes were rare in our Japanese subjects, an association was seen between the heterozygous Gln27/Glu27 genotype and obesity. The association between the Glu27 allele and obesity was observed in both male and female subjects. All of the Glu27 homozygotes were homozygous for the Gly16 allele, suggesting that the Gly16/Glu27 haplotype could be associated with obesity. Although the Gly16 variant and the Glu27 variant were in linkage disequilibrium, the incidence of Glu27 was much lower than that of Gly16. The frequency of Gly16/ Gln27 homozygotes was higher than that of Gly16/ Glu27 homozygotes both in non-obese (19 % vs 0.5 %) and obese subjects (13 % vs 3 %). This could be the reason why obesity was associated with Glu27, but not with Gly16, despite the linkage disequilibrium. Thus the haplotype that was associated with leanness in women could be Gly16/Gln27. The frequency of the variant Glu27 allele of the b2-AR gene was twofold higher in diabetic subjects (p = 0.001). The association between the Glu27 allele and diabetes could be explained by the high frequency of obesity in the subjects with diabetes. On the other hand, obese subjects carrying the Glu27 allele of the b2-AR gene showed higher concentrations of serum triglyceride than obese subjects without the variant allele despite equivalent concentrations of glycohaemoglobin. The ANOVA showed that both the Glu27 allele and glycohaemoglobin concentrations were independently associated with hypertriglyceridaemia in the obese group. The association was not observed in non-obese subjects, probably because relative contribution of lipolysis to triglyceride concentrations was small in lean subjects. In a recombinant expression system using fibroblasts as host cells it has been shown that the Glu27 variant receptor is resistant to agonist-promoted down-regulation as compared with wild type [7, 8] . The absence of down-regulation might augment the release of non-esterified fatty acid and thereby result in hypertriglyceridaemia and insulin resistance, although the mechanism by which the Gln27Glu substitution induces fat accumulation is not known. These observations contrasted with a report that the Arg64 allele of the b3-AR gene is associated with decreased serum triglyceride despite its association with visceral obesity, probably through the low lipolytic activity [10] . The incidence of Trp64Arg substitution was not increased in patients with diabetes [1, 2] . It should be noted that b2-ARs are expressed not only in adipose tissue but in a variety of tissues including artery of skeletal muscles and pancreatic beta-cells, which could affect insulin sensitivity and secretion. There is a possibility that the association of the polymorphism with obesity could be attributable to b2-ARs in tissue other than adipose tissue.
In conclusion, the amino-terminal polymorphisms in the b2-AR gene were associated with obesity and hypertriglyceridaemia in Japanese subjects. Furthermore, the Glu27 variant could be involved in the development of Type II diabetes through fat accumulation and insulin resistance.
